Osteoporosis drug can be effective in treating COVID-19 - scientists
The drug Raloxifene used for the prevention and treatment of osteoporosis can be effective in the treatment of COVID-19. This was reported by KBS with reference to the results of a study by experts from Gyeonggi Business Raloxifen is able to suppress the activity of coronavirus at the cellular level. According to experts, in addition to coronavirus, this drug can also be effective in the treatment of Middle Eastern respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS). It is known that representatives of institutions are currently preparing for the start of clinical trials.
Комментарии
Отправить комментарий